Related Experiment Video
Updated: Jan 15, 2026

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and
O Dormond1, A Foletti, C Paroz
1Centre Pluridisciplinaire d'Oncologie, University of Lausanne Medical School, Lausanne, Switzerland.
Abstract:
Cyclooxygenase-2 (COX-2), a key enzyme in arachidonic acid metabolism, is overexpressed in many cancers. Inhibition of COX-2 by nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk of cancer development in humans and suppresses tumor growth in animal models. The anti-cancer effect of NSAIDs seems to involve suppression of tumor angiogenesis, but the underlying mechanism is not completely understood. Integrin alpha V beta 3 is an adhesion receptor critically involved in mediating tumor angiogenesis. Here we show that inhibition of endothelial-cell COX-2 by NSAIDs suppresses alpha V beta 3-dependent activation of the small GTPases Cdc42 and Rac, resulting in inhibition of endothelial-cell spreading and migration in vitro and suppression of fibroblast growth factor-2-induced angiogenesis in vivo. These results establish a novel functional link between COX-2, integrin alpha V beta 3 and Cdc42-/Rac-dependent endothelial-cell migration. Moreover, they provide a rationale to the understanding of the anti-angiogenic activity of NSAIDs.
Insights
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cancer by blocking endothelial-cell cyclooxygenase-2 (COX-2). This suppresses angiogenesis by affecting integrin alpha V beta 3 and small GTPases, hindering tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cyclooxygenase-2 (COX-2) is overexpressed in many cancers and is a target for nonsteroidal anti-inflammatory drugs (NSAIDs).
- NSAIDs inhibit cancer development and tumor growth, potentially through anti-angiogenic mechanisms, but the precise pathways are unclear.
- Integrin alpha V beta 3 is crucial for tumor angiogenesis.
Purpose of the Study:
- To investigate the mechanism by which NSAIDs suppress tumor angiogenesis.
- To elucidate the role of endothelial-cell COX-2 in regulating integrin alpha V beta 3 signaling and angiogenesis.
Main Methods:
- Inhibition of endothelial-cell COX-2 using NSAIDs.
- Assessment of alpha V beta 3-dependent activation of small GTPases (Cdc42 and Rac).
- In vitro assays for endothelial-cell spreading and migration.
- In vivo studies of fibroblast growth factor-2-induced angiogenesis.
Main Results:
- NSAID-mediated inhibition of endothelial-cell COX-2 suppressed alpha V beta 3-dependent activation of Cdc42 and Rac.
- Endothelial-cell spreading and migration were inhibited in vitro.
- Fibroblast growth factor-2-induced angiogenesis was suppressed in vivo.
Conclusions:
- A novel link exists between COX-2, integrin alpha V beta 3, and Cdc42/Rac-dependent endothelial-cell migration.
- These findings provide a mechanistic understanding of the anti-angiogenic effects of NSAIDs in cancer therapy.
Related Concept Videos
07:52In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
08:54In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression
11:53A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer
10:19Generation of Genetically Modified Mice through the Microinjection of Oocytes
13:10DNA Vector-based RNA Interference to Study Gene Function in Cancer
10:58Quantitative and Automated High-throughput Genome-wide RNAi Screens in C. elegans

